Managing OFF Time in Parkinson’s Disease

In this episode, ‘Managing OFF Time in Parkinson’s Disease,’ the expert neurologist explores how multiple therapeutic approaches are used to manage motor fluctuations and dyskinesia in patients with Parkinson’s disease. The discussion highlights the role of on-demand subcutaneous apomorphine injections in rapidly addressing OFF periods, particularly during challenging times such as the morning. The clinician also explains how extended-release amantadine works beyond dopaminergic pathways, targeting NMDA receptors to help reduce both dyskinesia and OFF time.

The patient shares firsthand experience with incorporating these therapies into daily life, describing how injectable apomorphine provided rapid symptom relief within minutes and helped smooth fluctuations throughout the day. The addition of extended-release amantadine further improved symptom control, reducing dyskinesia and enhancing sleep quality. Despite these advances, the patient notes that OFF time persisted, often occurring unpredictably and at inconvenient moments, highlighting the limitations of even well-optimized treatment regimens.

Throughout the conversation, the panel underscores the complexity of managing Parkinson’s disease as it progresses. Even with combination therapy, including long-acting levodopa, on-demand injections, and adjunctive treatments, achieving consistent symptom control remains challenging. The expert neurologist emphasizes the importance of individualized care and ongoing treatment adjustments, while the patient reinforces the frustration and unpredictability associated with residual OFF time. Together, the discussion illustrates the need for continued therapeutic innovation and proactive management to improve patient outcomes.

The next episode in this series, ‘Advanced Therapy with Apomorphine Pump in Parkinson’s Disease,’ features the panelists discussing the transition to infusion therapy and its impact on symptom control and daily life. The conversation highlights treatment eligibility, patient concerns, and the real-world benefits of improved predictability and independence.